Levofloxacin Treatment Failure In Haemophilus Influenzae Pneumonia

Vista senzilla d'ítem
dc.contributor.authorBastida, Teresa
dc.contributor.authorPérez Vázquez, María
dc.contributor.authorCampos, José
dc.contributor.authorCortes Lletget, María Cristina
dc.contributor.authorRomán, Federico
dc.contributor.authorTubau, Fe
dc.contributor.authorCampa, Adela G. de la
dc.contributor.authorAlonso Tarrés, Carles
dc.date.accessioned2018-11-23T12:35:49Z
dc.date.available2018-11-23T12:35:49Z
dc.date.issued2003-11
dc.date.updated2018-07-25T10:48:08Z
dc.description.abstractWe describe the first case of failure of oral levofloxacin treatment of community-acquired pneumonia caused by Haemophilus influenzae. The strain showed cross-resistance to fluoroquinolones and carried four mutations in quinolone resistance-determining regions of DNA gyrase and topoisomerase IV genes.
dc.format.extent4 p.
dc.format.mimetypeapplication/pdf
dc.identifier.urihttps://hdl.handle.net/2445/126390
dc.language.isoeng
dc.publisherCenters for Disease Control and Prevention
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3201/eid0911.030176
dc.relation.ispartofEmerging Infectious Diseases, 2003, vol. 9, num. 11, p. 1475-1478
dc.relation.urihttps://doi.org/10.3201/eid0911.030176
dc.rightsDomini públic / Public domain
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/publicdomain/zero/1.0/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationPneumònia
dc.subject.classificationBacils
dc.subject.otherPneumonia
dc.subject.otherBacillus (Bacteria)
dc.titleLevofloxacin Treatment Failure In Haemophilus Influenzae Pneumonia
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Miniatura
Nom:
BastidaT.pdf
Mida:
402.29 KB
Format:
Adobe Portable Document Format
Descarregar

Col·leccions

Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))